ReviewFrontiers in immunology2022

Immune Checkpoint Inhibitors in Tumors Harboring Homologous Recombination Deficiency: Challenges in Attaining Efficacy.

Saulo Brito Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.